VANGUARD GROUP INC 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | CymaBay Therapeutics, Inc. CBAY | VANGUARD GROUP INC | 6,306,149 5.560% | 2,879,138 (+84.01%) | Filing |
| 2021-02-10 10:46 am Sale | 2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | VANGUARD GROUP INC | 3,427,011 4.970% | -264,314 (-7.16%) | Filing |